Simultaneous HPLC analysis of triamcinolone acetonide and budesonide in microdialysate and rat plasma: application to a pharmacokinetic study

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 1;878(29):2967-73. doi: 10.1016/j.jchromb.2010.08.048. Epub 2010 Sep 9.

Abstract

A specific and reliable HPLC-PDA method for the quantitative determination of triamcinolone acetonide, budesonide and fluticasone propionate (as internal standards) in small volumes of microdialysate and rat plasma was developed. An efficient solid-phase extraction (SPE) procedure for plasma samples yielded extremely clean extracts with overall recovery of 104.3% and 95.7% for triamcinolone acetonide (TA) and fluticasone propionate, respectively. Plasma extracts obtained after SPE and microdialysis samples were directly injected on a C18 column to separation. The method has been validated with good linearity, sensitivity, specificity and high accuracy (RE -5.28% to 9.14%) and precision (CV 0.50% to 6.62%) on both matrices. In stability studies, TA and budesonide were stable during storage and assay procedures. The method was applied to a pharmacokinetic study in rodents using microdialysis to determine protein unbound TA concentrations in blood and muscle.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / blood*
  • Anti-Inflammatory Agents / pharmacokinetics
  • Budesonide / blood*
  • Budesonide / pharmacokinetics
  • Chromatography, High Pressure Liquid / methods*
  • Male
  • Microdialysis
  • Muscles / chemistry
  • Rats
  • Solid Phase Extraction
  • Triamcinolone Acetonide / blood*
  • Triamcinolone Acetonide / pharmacokinetics

Substances

  • Anti-Inflammatory Agents
  • Budesonide
  • Triamcinolone Acetonide